Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE:002332)
China
· Delayed Price · Currency is CNY 9.12
+0.06 (0.66%)
Mar 10, 2026, 2:14 PM CST
SHE:002332 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 8,962 | 9,833 | 12,632 | 11,178 | 13,058 | 13,216 | Upgrade
|
| Market Cap Growth | -10.74% | -22.16% | 13.01% | -14.39% | -1.20% | 46.14% | Upgrade
|
| Enterprise Value | 7,967 | 8,693 | 11,208 | 10,046 | 12,828 | 13,835 | Upgrade
|
| Last Close Price | 9.06 | 9.52 | 11.94 | 10.35 | 11.90 | 11.91 | Upgrade
|
| PE Ratio | 32.87 | 24.76 | 22.43 | 14.92 | 21.08 | 26.20 | Upgrade
|
| Forward PE | 15.62 | 12.86 | 17.64 | 14.26 | 16.42 | 19.94 | Upgrade
|
| PS Ratio | 2.50 | 2.46 | 3.06 | 2.55 | 3.00 | 3.29 | Upgrade
|
| PB Ratio | 1.49 | 1.67 | 2.17 | 2.03 | 2.64 | 2.88 | Upgrade
|
| P/TBV Ratio | 1.72 | 1.92 | 2.52 | 2.38 | 3.19 | 3.63 | Upgrade
|
| P/FCF Ratio | 85.95 | 51.46 | 35.01 | 34.21 | 31.90 | 19.69 | Upgrade
|
| P/OCF Ratio | 29.03 | 24.67 | 21.21 | 18.35 | 19.85 | 16.75 | Upgrade
|
| EV/Sales Ratio | 2.22 | 2.17 | 2.72 | 2.29 | 2.94 | 3.44 | Upgrade
|
| EV/EBITDA Ratio | 11.78 | 10.41 | 13.73 | 11.60 | 14.97 | 16.93 | Upgrade
|
| EV/EBIT Ratio | 17.80 | 14.08 | 18.53 | 14.80 | 19.06 | 21.62 | Upgrade
|
| EV/FCF Ratio | 76.41 | 45.50 | 31.06 | 30.75 | 31.34 | 20.62 | Upgrade
|
| Debt / Equity Ratio | 0.05 | 0.01 | 0.04 | 0.06 | 0.15 | 0.26 | Upgrade
|
| Debt / EBITDA Ratio | 0.41 | 0.07 | 0.27 | 0.40 | 0.86 | 1.44 | Upgrade
|
| Debt / FCF Ratio | 2.68 | 0.31 | 0.61 | 1.05 | 1.81 | 1.76 | Upgrade
|
| Net Debt / Equity Ratio | -0.17 | -0.22 | -0.25 | -0.25 | -0.21 | -0.17 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.53 | -1.58 | -1.76 | -1.59 | -1.20 | -0.93 | Upgrade
|
| Net Debt / FCF Ratio | -9.86 | -6.92 | -3.99 | -4.21 | -2.51 | -1.13 | Upgrade
|
| Asset Turnover | 0.51 | 0.57 | 0.60 | 0.65 | 0.64 | 0.64 | Upgrade
|
| Inventory Turnover | 1.48 | 1.88 | 2.17 | 2.07 | 2.26 | 2.58 | Upgrade
|
| Quick Ratio | 2.12 | 2.94 | 2.29 | 2.58 | 1.83 | 1.78 | Upgrade
|
| Current Ratio | 3.06 | 4.20 | 3.25 | 3.54 | 2.57 | 2.32 | Upgrade
|
| Return on Equity (ROE) | 4.18% | 6.83% | 9.92% | 14.29% | 13.04% | 13.85% | Upgrade
|
| Return on Assets (ROA) | 3.95% | 5.52% | 5.51% | 6.30% | 6.20% | 6.32% | Upgrade
|
| Return on Invested Capital (ROIC) | 6.84% | 11.07% | 12.44% | 14.45% | 14.79% | 14.34% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.30% | 9.90% | 10.20% | 11.80% | 12.60% | 12.30% | Upgrade
|
| Earnings Yield | 3.05% | 4.04% | 4.46% | 6.70% | 4.74% | 3.82% | Upgrade
|
| FCF Yield | 1.16% | 1.94% | 2.86% | 2.92% | 3.14% | 5.08% | Upgrade
|
| Dividend Yield | 2.21% | 3.15% | 2.51% | 2.90% | 1.26% | 1.26% | Upgrade
|
| Payout Ratio | 109.64% | 75.08% | 53.24% | 20.58% | 27.79% | 28.22% | Upgrade
|
| Buyback Yield / Dilution | -0.54% | -0.51% | 0.13% | -0.00% | -7.84% | -0.59% | Upgrade
|
| Total Shareholder Return | 1.66% | 2.64% | 2.65% | 2.90% | -6.58% | 0.67% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.